Motion Sickness

Product NDC: 59779-198
11-digit product format: 597790198
Labeler code: 59779
Product ID: 59779-198_e72c2541-7d9f-435a-8ca7-c9d9fa116ea3
Type: HUMAN OTC DRUG
Nonproprietary name: Dimenhydrinate
Dosage form: TABLET
Route: ORAL
Labeler: CVS Pharmacy
Application: M009
Marketing category: OTC MONOGRAPH DRUG
Marketing start: 1992-12-01
Substance: DIMENHYDRINATE
Active strength: 50 mg/1
Pharmacologic classes: Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	59779-198	59779-198-21	D	Discontinued by firm		2026-10-12

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 36 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	59779-198-21	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	59779-198-07	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	59779-198-21	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	59779-198-07	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	59779-198-21	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	59779-198-07	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	59779-198-21	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	59779-198-07	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	59779-198-21	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	59779-198-07	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	59779-198-21	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	59779-198-07	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	59779-198-21	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	59779-198-07	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	59779-198-21	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	59779-198-07	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	59779-198-21	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	59779-198-07	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	59779-198-21	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	59779-198-07	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	59779-198-21	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	59779-198-07	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	59779-198-21	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	59779-198-07	`557ba5c1ecfa…`	`9c80585c8c6e…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: Motion Sickness
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
DIMENHYDRINATE	50 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
JB937PER5C	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
198603	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
0998947c-cfba-497e-bf7a-9c7f8fff1764	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
0e2e0f88-b076-afe1-4bdd-32bca4375bec	Product name	3	20250127
3e48c9c4-918d-5d23-2f0b-d2398b06be54	Product name	1	20140508
865c72dd-0d94-daac-f728-ddd4ded2a79e	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
59779-198-02	Motion Sickness	2 in 1 CARTON	TABLET	2	16
59779-198-02	Motion Sickness	6 in 1 BLISTER PACK	TABLET	6	16
59779-198-07	Motion Sickness	6 in 1 BLISTER PACK	TABLET	6	16
59779-198-07	Motion Sickness	6 in 1 CARTON	TABLET	6	16
59779-198-21	Motion Sickness	1 in 1 CARTON	TABLET	1	16
59779-198-21	Motion Sickness	16 in 1 VIAL	TABLET	16	16

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
DIMENHYDRINATE	ACTIVE INGREDIENT	JB937PER5C	MOTION SICKNESS (DIMENHYDRINATE) TABLET [WOONSOCKET PRESCRIPTION CENTER,INCORPORATED]	7
DIPHENHYDRAMINE	ACTIVE MOIETY	8GTS82S83M	MOTION SICKNESS (DIMENHYDRINATE) TABLET [WOONSOCKET PRESCRIPTION CENTER,INCORPORATED]	7
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS	INACTIVE INGREDIENT	L11K75P92J	MOTION SICKNESS (DIMENHYDRINATE) TABLET [WOONSOCKET PRESCRIPTION CENTER,INCORPORATED]	7
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	MOTION SICKNESS (DIMENHYDRINATE) TABLET [WOONSOCKET PRESCRIPTION CENTER,INCORPORATED]	7
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	MOTION SICKNESS (DIMENHYDRINATE) TABLET [WOONSOCKET PRESCRIPTION CENTER,INCORPORATED]	7
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	MOTION SICKNESS (DIMENHYDRINATE) TABLET [WOONSOCKET PRESCRIPTION CENTER,INCORPORATED]	7
STEARIC ACID	INACTIVE INGREDIENT	4ELV7Z65AP	MOTION SICKNESS (DIMENHYDRINATE) TABLET [WOONSOCKET PRESCRIPTION CENTER,INCORPORATED]	7

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 4 of 6 · 107 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Dramamine for Kids	DIMENHYDRINATE	Medtech Products Inc.	12bc3f17-ed62-4d0d-9b1e-3835579e711b	2025-09-10	Warnings	Exact identifier application number: M009
Medique Medi-Meclizine	MECLIZINE HCL	Unifirst First Aid Corporation	b3fec2df-c41d-0b56-e053-2995a90a35e8	2025-09-09	Warnings	Exact identifier application number: M009
Motion Sickness Relief	MECLIZINE HYDROCHLORIDE	TARGET CORPORATION	36ba2950-4a09-e5de-e063-6394a90a1771	2025-09-04	Warnings	Exact identifier application number: M009
MECLIZINE	MECLIZINE HCL 12.5 MG	Advanced Rx LLC	032a89f2-17e7-45d2-94a1-cc7a601ebdee	2025-09-01	Warnings	Exact identifier application number: M009
Dimenhydrinate	DIMENHYDRINATE	Major Pharmaceuticals	78d22836-a442-7c0c-e053-2991aa0a62f3	2025-08-13	Warnings	Exact identifier application number: M009
MQ Motion Patch	MOTION PATCH	Zhengzhou Miaoqi Medical Technology Co., Ltd.	3a70bc22-8e31-2d4c-e063-6394a90a3b24	2025-07-21	Warnings	Exact identifier application number: M009
Bangbrek Bee Venom Wart Corn Callus Remover	SALICYLIC ACID 17%	Brilliance Trade LLC	377946a0-0e8c-70f4-e063-6294a90a1d85	2025-06-20	Warnings	Exact identifier application number: M009
Dramamine for Kids	DIMENHYDRINATE	Medtech Products Inc.	48e2e9ef-4c88-42ef-b825-d1b007475275	2025-05-06	Warnings	Exact identifier application number: M009
BONINE MAX	MECLIZINE HYDROCHLORIDE	WellSpring Pharmaceutical Corporation	7326a47e-284e-4b6f-8eb0-7933dc1e3f0d	2025-04-11	Warnings	Exact identifier application number: M009
Meclizine HCL 25 mg	MECLIZINE HCL	Bryant Ranch Prepack	d1c58a74-5455-4a07-bcb6-cc114032ed12	2025-03-31	Warnings	Exact identifier application number: M009
BONINE	MECLIZINE HYDROCHLORIDE	WellSpring Pharmaceutical Corporation	ad3d66ca-a52c-43ba-b9e2-6269b8a413a9	2025-03-21	Warnings	Exact identifier application number: M009
BONINE	MECLIZINE HYDROCHLORIDE	WellSpring Pharmaceutical Corporation	0b2ea6b8-b342-4940-8922-898758fbeb31	2025-03-21	Warnings	Exact identifier application number: M009
Meclizine Hydrochloride	MECLIZINE HYDROCHLORIDE	Walgreen Company	ecf8d05e-0e77-f3e8-e053-2a95a90a6604	2025-03-11	Warnings	Exact identifier application number: M009
MECLIZINE	MECLIZINE HCL 25MG	PD-Rx Pharmaceuticals, Inc.	cf79ac74-017e-4fb4-85d3-4ea944080e89	2025-03-06	Warnings	Exact identifier application number: M009
HIONFURT Motion Sickness	MOTION SICKNESS NATURAL HERBAL PLANT	Puning Huiyu E-Commerce Co., Ltd.	2e2c9073-1dcf-a3e8-e063-6394a90a6ee3	2025-02-15	Warnings	Exact identifier application number: M009
HIONFURT Motion Sickness	MOTION SICKNESS NATURAL HERBAL PLANT LEMON	Puning Huiyu E-Commerce Co., Ltd.	2e2b3729-f8b0-605f-e063-6294a90a90c8	2025-02-15	Warnings	Exact identifier application number: M009
HIONFURT Motion Sickness	MOTION SICKNESS NATURAL HERBAL PLANT LAVENDER	Puning Huiyu E-Commerce Co., Ltd.	2e30b09d-838d-59fb-e063-6394a90aa984	2025-02-15	Warnings	Exact identifier application number: M009
HIONFURT Motion Sickness	MOTION SICKNESS PREVENT NAUSEA,DIZZINESS VOMITING	Puning Huiyu E-Commerce Co., Ltd.	2e31419e-3ccd-d7b5-e063-6394a90ac765	2025-02-15	Warnings	Exact identifier application number: M009
Dramamine for Kids	DIMENHYDRINATE	Medtech Products Inc.	3ccd6eb4-ba7e-4a6a-abb9-a6ef3196240c	2025-02-12	Warnings	Exact identifier application number: M009
Motion Sickness	MOTION SICKNESS NATURAL HERBAL PLANT	Puning Huiyu E-Commerce Co., Ltd.	2db09ade-c94b-5f5f-e063-6394a90af9dc	2025-02-09	Warnings	Exact identifier application number: M009

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
JB937PER5C	DIMENHYDRINATE	523-87-5	DIMENHYDRINATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
198603	dimenhyDRINATE 50 MG Oral Tablet	PSN	0998947c-cfba-497e-bf7a-9c7f8fff1764	16
198603	dimenhydrinate 50 MG Oral Tablet	SCD	0998947c-cfba-497e-bf7a-9c7f8fff1764	16

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
59779-198-02	59779019802	2 BLISTER PACK in 1 CARTON (59779-198-02) / 6 TABLET in 1 BLISTER PACK	2 blister pack	1992-12-01		No	No	Current
59779-198-07	59779019807	6 BLISTER PACK in 1 CARTON (59779-198-07) / 6 TABLET in 1 BLISTER PACK	6 blister pack	1992-12-01	0000-00-00	No	No	Current
59779-198-21	59779019821	1 in 1 CARTON						Historical